[Federal Register Volume 81, Number 165 (Thursday, August 25, 2016)]
[Rules and Regulations]
[Page 58395]
[FR Doc No: 2016-20368]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 117

[Docket No. USCG-2016-0817]

Drawbridge Operation Regulation; Columbia River, Portland, OR and
Vancouver, WA

AGENCY: Coast Guard, DHS.

ACTION: Notice of deviation from drawbridge regulation.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard has issued a temporary deviation from the
operating schedule that governs the Interstate 5 (I-5) Bridges across
the Columbia River, mile 106.5, between Portland, Oregon, and
Vancouver, Washington. The deviation is necessary to facilitate the
movement and safety of pedestrians on the I-5 Bridges. This deviation
allows the bridges to remain in the closed-to-navigation position
during the Hands Across the Bridge event.

DATES: This deviation is effective from 10 a.m. to 1 p.m. on September
5, 2016.

ADDRESSES: The docket for this deviation, [USCG-2016-0XXX] is available
at http://www.regulations.gov. Type the docket number in the ``SEARCH''
box and click ``SEARCH.'' Click on Open Docket Folder on the line
associated with this deviation.

FOR FURTHER INFORMATION CONTACT: If you have questions on this
temporary deviation, call or email Mr. Steven Fischer, Bridge
Administrator, Thirteenth Coast Guard District; telephone<PHONE_NUMBER>,
email<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: The Oregon Department of Transportation has
requested that the Interstate 5 (I-5) Bridges across the Columbia River
remain closed to vessel traffic to facilitate heavier than normal
pedestrian traffic associated with Hands Across the Bridges event. The
I-5 Bridges cross the Columbia River at mile 106.5, and provide three
designated navigation channels with vertical clearances ranging from 39
to 72 feet above Columbia River Datum 0.0 while the lift spans are in
the closed-to-navigation position. The normal operating schedule for
the I-5 Bridges is 33 CFR 117.869. This deviation period is from 10
a.m. to 1 p.m. on September 5, 2016. The deviation allows the lift
spans of the I-5 Bridges to remain in the closed-to-navigation
position, and need not open for maritime traffic during this period.
The bridges shall operate in accordance with 33 CFR 117.869 at all
other times. Waterway usage on this part of the Columbia River includes
vessels ranging from commercial tug and tow vessels to recreational
pleasure craft.
    Vessels able to pass under the bridges in the closed positions may
do so at anytime. The bridges will be able to open for emergencies and
there is no immediate alternate route for vessels to pass. The Coast
Guard will also inform the users of the waterways through our Local and
Broadcast Notices to Mariners of the change in operating schedule for
the bridge so that vessels can arrange their transits to minimize any
impact caused by the temporary deviation.
    In accordance with 33 CFR 117.35(e), the drawbridges must return to
their regular operating schedule immediately at the end of the
effective period of this temporary deviation. This deviation from the
operating regulations is authorized under 33 CFR 117.35.

    Dated: August 19, 2016.
Steven M. Fischer,
Bridge Administrator, Thirteenth Coast Guard District.
[FR Doc. 2016-20368 Filed 8-24-16; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register: February 2, 2010 (Volume 75, Number 21)]
[Notices]
[Page 5332]
[DOCID:fr02fe10-77]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0420]

Brian Ullom: Debarment Order

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is issuing an order
under the Federal Food, Drug, and Cosmetic Act (the act) permanently
debarring Brian Ullom from providing services in any capacity to a
person that has an approved or pending drug product application. We
base this order on a finding that Mr. Ullom was convicted of a felony
under Federal law for conduct relating to the regulation of a drug
product under the act. Mr. Ullom was given notice of the proposed
permanent debarment and an opportunity to request a hearing within the
timeframe prescribed by regulation. As of December 2, 2009, Mr. Ullom
failed to respond. Mr. Ullom's failure to respond constitutes a waiver
of his right to a hearing concerning this action.

DATES: This order is effective February 2, 2010.

ADDRESSES: Submit applications for special termination of debarment to
the Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Kenny Shade, Office of Regulatory
Affairs (HFC-230), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    Section 306(a)(2)(B) of the act (21 U.S.C. 335a(a)(2)(B)) requires
debarment of an individual if FDA finds that the individual has been
convicted of a felony under Federal law for conduct otherwise relating
to the regulation of any drug product under the act.
    On August 17, 2009, the U.S. District Court for the Western
District of Kentucky entered judgment against Brian Ullom for one count
of participation in a scheme to defraud health care benefit programs by
billing patients and patients' health care benefit programs, including
Medicare and Medicaid, for prescription drug samples and for
prescriptions that were never filled, in violation of 18 U.S.C. 1347;
and one count of knowingly selling, purchasing and trading prescription
drug samples with the intent to defraud, in violation of sections
301(t) and 503(c)(1) of the act (21 U.S.C. 331(t) and 353(c)(1)).
    FDA's finding that debarment is appropriate is based on the felony
conviction related to the sale of drug samples. The factual basis for
this conviction is as follows: Beginning in or about 2002 and
continuing until on or about October 12, 2006, Mr. Ullom, with the
intent to defraud, knowingly sold, purchased, and traded prescription
drug samples. During that time period, Mr. Ullom obtained prescription
drug samples by purchasing the drug samples from others, including a
local physician and a pharmaceutical sales representative. After
obtaining the samples, he removed the drugs from their original sample
packaging and sold them to the public through his pharmacy. At the time
of sale, he knew the drugs were samples, and he resold them with the
intent to defraud and mislead the purchaser by selling the sample drugs
as drugs properly obtained and dispensed.
    As a result of this conviction, FDA sent Mr. Ullom by certified
mail on October 27, 2009, a notice proposing to permanently debar him
from providing services in any capacity to a person that has an
approved or pending drug product application. The proposal was based on
a finding, under section 306(a)(2)(B) of the act that Brian Ullom was
convicted of a felony under Federal law for conduct relating to the
regulation of a drug product under the act. In accordance with section
306(i) of the act and part 12 (21 CFR part 12), the proposal also
offered Mr. Ullom an opportunity to request a hearing, providing him 30
days from the date of receipt of the letter in which to file the
request, and advised him that failure to request a hearing constituted
a waiver of the opportunity for a hearing and of any contentions
concerning this action. Accordingly, Mr. Ullom had to request a hearing
by December 2, 2009. As of December 2, 2009, Mr. Ullom had not
responded to the notice. Mr. Ullom thus failed to respond within the
timeframe prescribed by regulation and as a result has waived both his
opportunity for a hearing and waived any contentions concerning his
debarment (21 U.S.C. 335(a)(i); part 12)).

II. Findings and Order

    Therefore, the Acting Director, Office of Enforcement, Office of
Regulatory Affairs, under section 306(a)(2)(B) of the act, under
authority delegated to the Acting Director (Staff Manual Guide
1410.35), finds that Brian Ullom has been convicted of a felony under
Federal law for conduct relating to the regulation of a drug product
under the act.
    As a result of the foregoing finding, Mr. Ullom is permanently
debarred from providing services in any capacity to a person with an
approved or pending drug product application under sections 505, 512,
or 802 of the act (21 U.S.C. 355, 360b, or 382), or under section 351
of the Public Health Service Act (42 U.S.C. 262), effective (see DATES)
(see sections 306(c)(1)(B), (c)(2)(A)(ii), and 201(dd) of the act (21
U.S.C. 321(dd))). Any person with an approved or pending drug product
application who knowingly employs or retains as a consultant or
contractor, or otherwise uses the services of Brian Ullom, in any
capacity, during Mr. Ullom's debarment, will be subject to civil money
penalties (section 307(a)(6) of the act (21 U.S.C. 335b(a)(6))). If Mr.
Ullom, during his period of debarment, provides services in any
capacity to a person with an approved or pending drug product
application, he will be subject to civil money penalties (section
307(a)(7) of the act. In addition, FDA will not accept or review any
abbreviated new drug applications submitted by or with the assistance
of Mr. Ullom during his period of debarment (section 306(c)(1)(B) of
the act).
    Any application by Mr. Ullom for special termination of debarment
under section 306(d)(4) of the act should be identified with Docket No.
FDA-2009-N-0420 and sent to the Division of Dockets Management (see
ADDRESSES). All such submissions are to be filed in four copies. The
public availability of information in these submissions is governed by
21 CFR 10.20(j).
    Publicly available submissions may be seen in the Division of
Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: January 8, 2010.
Brenda Holman,
Acting Director, Office of Enforcement, Office of Regulatory Affairs.
[FR Doc. 2010-2135 Filed 2-1-10; 8:45 am]
BILLING CODE 4160-01-S


[Federal Register Volume 81, Number 100 (Tuesday, May 24, 2016)]
[Notices]
[Page 32821]
[FR Doc No: 2016-12115]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Submission for OMB Review; Comment Request

Upon Written Request, Copies Available From: Securities and Exchange
Commission, Office of FOIA Services, 100 F Street NE., Washington, DC
20549-2736.

Extension: Rule 17Ad-17.
    SEC File No. 270-412, OMB Control No. 3235-0469.

    Notice is hereby given that pursuant to the Paperwork Reduction Act
of 1995 (``PRA'') (44 U.S.C. 3501 et seq.), the Securities and Exchange
Commission (``Commission'') has submitted to the Office of Management
and Budget (``OMB'') a request for approval of extension of the
previously approved collection of information provided for in Rule
17Ad-2(c), (d), and (h), (17 CFR 240.17Ad-2(c), (d), and (h)), under
the Securities Exchange Act of 1934 (15 U.S.C. 78a et seq.).
    Rule 17Ad-17 requires transfer agents and broker-dealers to make
two searches for the correct address of lost securityholders using an
information database without charge to the lost securityholders. In
addition, paying agents are required to attempt to notify lost payees
at least once. The Commission staff estimates that the rule applies to
approximately 301 broker dealers and 2,766 paying agent entities,
including carrying firms, transfer agents, indenture trustees,
custodians, and approximately 10% of issuers. The Commission staff
estimates that the total burden is 88,619 hours, representing the hours
associated with searches and notifications. Approximately 2,686 hours
are associated with recordkeeping.
    The retention period for the recordkeeping requirement under Rule
17Ad-17 is not less than three years following the date the notice is
submitted. The recordkeeping requirement under this rule is mandatory
to assist the Commission in monitoring compliance with the rule. This
rule does not involve the collection of confidential information.
    An agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information under the PRA unless it
displays a currently valid OMB control number.
    The public may view background documentation for this information
collection at the following Web site: www.reginfo.gov. Comments should
be directed to: (i) Desk Officer for the Securities and Exchange
Commission, Office of Information and Regulatory Affairs, Office of
Management and Budget, Room 10102, New Executive Office Building,
Washington, DC 20503, or by sending an email to:
<EMAIL_ADDRESS>and (ii) Pamela Dyson, Director/Chief
Information Officer, Securities and Exchange Commission, c/o Remi
Pavlik-Simon, 100 F Street NE., Washington, DC 20549, or by sending an
email to<EMAIL_ADDRESS>Comments must be submitted to OMB within
30 days of this notice.

    Dated: May 18, 2016.
Robert W. Errett,
Deputy Secretary.
[FR Doc. 2016-12115 Filed 5-23-16; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register: May 22, 2006 (Volume 71, Number 98)]
[Notices]
[Page 29325]
[DOCID:fr22my06-37]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP99-301-142]

ANR Pipeline Company; Notice of Negotiated Rate Filing Amendment

May 12, 2006.
    Take notice that on May 8, 2006, ANR Pipeline Company (ANR)
tendered for filing and approval an amendment to an existing negotiated
rate service arrangement, which provided solely for the name change of
the customer.
    ANR requests that the Commission accept and approve the subject
amendment filing to be effective May 1, 2006.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed in accordance with the provisions of
Section 154.210 of the Commission's regulations (18 CFR 154.210).
Anyone filing an intervention or protest must serve a copy of that
document on the Applicant. Anyone filing an intervention or protest on
or before the intervention or protest date need not serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Magalie R. Salas,
Secretary.
 [FR Doc. E6-7693 Filed 5-19-06; 8:45 am]

BILLING CODE 6717-01-P